ArticleScientific reports2025
Influence of pyridyl nitrogen's position and hydrogen bonding interactions on antibacterial activities investigated by in vitro and in silico.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pyridine derivatives are multifunctional materials with various biological activities viz., antibacterial, antiviral, anticancer, antihistamine, etc. and are also the building blocks in supramolecular chemistry. Schiff's base compounds are known for their diversified applications / functionalities. A Schiff base with a pyridine moiety in its molecular structure is anticipated with potential biological activity. In order to study the effect of position of a pyridyl nitrogen on the antibacterial activity, two Schiff's bases containing pyridine moiety viz., 3-chloro-4-fluoro-N-((pyridin-3-yl)methylene)benzenamine (3Py) and 3-chloro-4-fluoro-N-((pyridin-4-yl)methylene)benzenamine (4Py), were prepared by condensing 4-fluoro-3-chloro-aniline with 3-pyridinecarboxaldehyde and 4-pyridinecarboxaldehyde. Pyridine derivatives form a hetero synthon type intermolecular hydrogen bonding interactions with substituted benzoic acids. The lower homologues of 4-n-alkyloxybenzoic acids (nOBAs, ethyl, propyl and butyl homologues) were treated with the pyridine derivatives, 3Py and 4Py and were observed to be involved in intermolecular hydrogen bonding (HB) interactions. The pyridine derivatives (3Py and 4Py), benzoic acid derivatives and their 1:1 molar ratio complex were subjected to antibacterial activities through in vitro and in silico techniques. The antibacterial activities of the pristine compounds and their HB complexes against Gram-positive, Staphylococcus aureus and Gram-negative, Escherichia coli bacteria were studied by paper disc diffusion method. The antibacterial activity of the compounds is evaluated for their interactions with the key enzymes viz., E. coli MurB and S. aureus GyraseB by in silico technique. The pyridyl nitrogen at 4th position of the Schiff base (4Py) showed effective inhibition towards the S. aureus whereas the pyridyl nitrogen at 3rd position (3Py) of the Schiff base showed effective inhibition towards the E. coli. The increase in alkyl chain length of carboxylic acids was found to decrease the antimicrobial activity in the pristine homologues. The HB interactions between 3Py and nOBA showed different antibacterial activities compared to that between 4Py and nOBA against E. coli and S. aureus. The experimental results were supported by molecular docking, molecular dynamics simulation and ADME/T analysis. The findings are consistent with experimental data, demonstrating that Schiff base 4Py exhibits greater inhibitory efficacy against S.aureus, while 3Py shows superior activity agains E. coli, compared to their respective HB complexes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.